Search results
Results from the WOW.Com Content Network
The Drug Enforcement Administration initiated a 2024 policy review to potentially reschedule marijuana as a Schedule III drug, amounting to "the agency's biggest policy change in more than 50 years". [4] Some hiring and retention policies in federal employment and the armed forces evolved during 2024.
It is currently illegal to grow, sell or use marijuana in most of North Carolina, except on Cherokee land in the western part of the state — where medical marijuana will soon be available for ...
Biden directed a review of marijuana scheduling in 2022. On May 16, he commented again on his commitment to changing federal laws on cannabis.
In February 2017, Morgan Griffith, a Virginia Republican, introduced H.R. 714, Legitimate Use of Medicinal Marijuana Act, that would move cannabis to Schedule II. [81] Griffith had introduced a bill under the same name in 2014. [82] In April 2017, Matt Gaetz, a Florida Republican, cosponsored House Resolution 2020 to move cannabis to Schedule III.
Biden called for rescheduling in 2022 and has repeatedly said that no one should be jailed just for marijuana possession or use. That doesn't mean rescheduling isn't without benefits.
The year 2022 began with several United States cannabis reform proposals pre-filed in 2021 for the upcoming year's legislative session. Among the remaining prohibitionist states, legalization of adult use in Delaware and Oklahoma was considered most likely, and Maryland, Ohio, Pennsylvania and Rhode Island somewhat less likely; medical cannabis in Mississippi was called likely at the beginning ...
The penalty for possessing marijuana in North Carolina depends on the type, how much you have and its use. Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 more ...
Timeline of Gallup polls in US on legalizing marijuana. [1]In the United States, cannabis is legal in 39 of 50 states for medical use and 24 states for recreational use. At the federal level, cannabis is classified as a Schedule I drug under the Controlled Substances Act, determined to have a high potential for abuse and no accepted medical use, prohibiting its use for any purpose. [2]